multilayer tablet exclusion criteria from PK analysis due to emesis [Regulatives / Guidelines]

posted by jag009  – NJ, 2016-01-30 00:02 (3304 d 05:29 ago) – Posting: # 15899
Views: 3,805

Hi Shuanghe,

But does it matter if it's IR/XR with a single API or IR with API A and XR with API B?
The emesis criteria should be based on the IR Tmax. Okay, unless there is an IR product out there which has a really long Tmax such that it's actually longer than the dosing interval of the modified release.

Thanks
John

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,665 registered users;
46 visitors (0 registered, 46 guests [including 8 identified bots]).
Forum time: 05:31 CET (Europe/Vienna)

When people learn no tools of judgment
and merely follow their hopes,
the seeds of political manipulation are sown.    Stephen Jay Gould

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5